2. TUBERCULOUS MENINGITS (TBM)
⢠Most common form of CNS tuberculosis
⢠If untreated, high frequency of Neurologic sequelae and Mortality
⢠TBM complicates 0.3% of untreated TB infections in children.
⢠Common between 6 mns and 4 yr of age
⢠Clinical progression of TBM may be rapid or gradual
ď Rupture of 1 or more Subependymal tubercle
⢠Rapid progression more often in infants and young children
⢠Occasionally, TBM occurs many years after the infection
TuberculousMeningitis
2
3. PATHOLOGY
Primary infection
Lymphohematogenous dissemination
Metastatic caseous lesion in the cerebral cortex or meninges
Discharges few tubercle bacilli into the subarachnoid space
Forms gelatinous exudate
Infiltrates the corticomeningeal blood vessels
Inflammation, obstruction & infarction of cerebral cortex
Brainstem (commonest site) Interferes CSF flow
Dysfunction of CN III, VI, and VII Hydrocephalus
TuberculousMeningitis
3
4. CLINICAL FEATURES # MRC STAGING
First stage
⢠Lasts for 1-2 week - Nonspecific symptoms
ďFever
ďHeadache
ďIrritability
ďDrowsiness
ďMalaise
⢠Stagnation or loss of developmental milestones
⢠Focal neurologic signs are absent
TuberculousMeningitis
4
5. Second stage
⢠Begins more abruptly
ďLethargy
ďNuchal rigidity / Hypertonia
ďSeizures
ďPositive Kernig and Brudzinski signs
ďCranial nerve palsies / Focal neurologic signs
ďHydrocephalus / Vasculitis
⢠Some with encephalitis
ďDisorientation
ďMovement disorders
ďSpeech impairment
TuberculousMeningitis
5
6. Third stage
⢠Coma
⢠Hemi or paraplegia
⢠Hypertension
⢠Decerebrate posturing
⢠Deterioration of vital signs
⢠Death
TuberculousMeningitis
6
7. DIAGNOSIS
⢠TST â Nonreactive in up to 50% of cases
⢠CXR - 20-50% of children have a normal findings
⢠HIV serology
⢠Lumbar CSF study
⢠Polymerase chain reaction (PCR)
⢠Cultures of other body fluids can help confirm the diagnosis
⢠Other Radiographic studies
TuberculousMeningitis
7
8. CSF Study
⢠CSF cells - leukocyte 10-500 cells/¾l
ďLymphocytes predominates
⢠CSF glucose - <40 mg/dl
⢠CSF Protein - markedly high (400-5,000 mg/dl)
⢠Early stage 1
ďViral aseptic meningitis then progress severely
⢠Success of CSF study related to its volume
⢠5-10 mL of lumbar CSF
ďAcid-fast stain positive in up to 30% of cases
ďculture is positive in 50-70% of cases
TuberculousMeningitis
8
9. Radiographic studies
CT or MRI - brain
⢠Normal during early stages of the disease
⢠As disease progresses
ďBasilar enhancement
ďCommunicating hydrocephalus
ďSigns of cerebral edema
⢠One or several clinically silent tuberculomas
ďMost often in the cerebral cortex or thalamic regions
TuberculousMeningitis
9
10. TUBERCULOMA
⢠Another manifestation of CNS tuberculosis
⢠Tumor-like mass
⢠Formed by aggregation of caseous tubercles
⢠Singular / multiple
⢠Clinically manifests as a brain tumor
⢠Account for up to 30% of brain tumors
TuberculousMeningitis
10
11. Location
⢠Supratentorial in adult
⢠Infratentorial in children
⢠At the base of the brain near the cerebellum
Clinical features
⢠Headache
⢠Vomiting
⢠Fever
⢠Focal neurologic findings
⢠Convulsions
TuberculousMeningitis
11
12. Diagnosis
⢠TST is usually reactive
⢠Chest radiograph is usually normal
⢠CT or MRI â brain
ďDiscrete lesions with surrounding edema
ďContrast medium enhancement shows ring-like lesion
⢠Surgical excision
ďTo distinguish tuberculoma from other causes of brain tumor
TuberculousMeningitis
12
13. Treatment
⢠Corticosteroids
ďAlleviates severe clinical signs and symptoms
ďUsed during 1st few weeks of treatment or
ďIn immediate post - op period to decrease cerebral edema
⢠Surgical removal is not necessary
ďMost tuberculomas resolve with medical management (Later)
TuberculousMeningitis
13
14. Tuberculoma Neurocysticercosis
Any age Rare before 3 years
Progressive neurological deficit No Progressive neurological deficit
Size >20 mm smaller
Irregular outline Regular rounded outline
Marked cerebral edema Less cerebral edema
Supra / infratentorial Usually Supratentorial
Midline shift seen Midline shift not seen
MRS has lipid peak MRS has no lipid peak
TuberculousMeningitis
14
17. COMPLICATIONS
⢠Hydrocephalus
⢠Stroke
⢠Opticochiasmatic â Arachnoiditis
ď Visual loss â During treatment with ATT / Withdrawal of steroids
⢠Seizures
TuberculousMeningitis
17
18. PROGNOSIS OF TBM
⢠Correlates most closely with
ďClinical stage of illness at the time treatment is initiated
⢠Most with 1st stage have an excellent outcome
⢠Most with 3rd stage, who survive have permanent disabilities
ďBlindness
ďDeafness
ďParaplegia
ďDiabetes insipidus
ďMental retardation
⢠Prognosis for young infants is worse than for older children
TuberculousMeningitis
18
19. TREATMENT
⢠ATT for 12 months
ďIntensive (2 months) + continuous phase (10 months)
⢠Why ? (Routine ATT regimen is 6 months)
ďHigh dosage for penetration of BBB
ďTo prevent relapse rates
⢠Children with TBM should be hospitalized
ďPreferably for first 2 months / Until clinically stabilized
TuberculousMeningitis
19
20. Internationally accepted ATT for TBM/Tuberculoma
⢠Intensive phase
ďśFour drugs (RHZE/S) are recommended for 2 months
⢠Continuation phase
ďśIsoniazid and Rifampicin are recommended for 10 months
⢠Corticosteroids (usually prednisone)
ďśHIV Negative
ď All children with TB meningitis at 2 mg/kg daily for 4 weeks
ď Then gradually tapered over 1â 2 weeks before stopping
ďśHIV Positive
ď Advised in the absence of life threatening opportunistic infections
TuberculousMeningitis
20
21. TAKE HOME MESSEGE
⢠ATT to be considered for any child who develops
ďBasilar meningitis
ďHydrocephalus
ďCranial nerve palsy
ďstroke with no other apparent etiology
⢠Often the key to the correct diagnosis
ďIdentifying an adult with TB who is in contact with the child
⢠TBM has short incubation period / Rapid progression
ďNeeds high index of suspicion
TuberculousMeningitis
21
22. REFERENCES
⢠Nelson textbook of pediatrics
⢠National guidelines for Extra pulmonary TB
ďIndex TB guidelines
⢠Google images
TuberculousMeningitis
22
25. TUBERCULIN SKIN TEST
Induration âĽ5 mm
⢠Close contact - known/suspected contagious people with TB
⢠Children suspected to have TB
⢠Findings on CXR consistent with active/previously TB disease
⢠Clinical evidence of tuberculosis disease
⢠Children receiving
ďImmunosuppressive therapy or
ďImmunosuppressive conditions - HIV infection
TuberculousMeningitis
25
26. Induration âĽ10 mm
⢠Children at increased risk of disseminated TB
⢠Children younger than 4 yr of age
⢠Children - Hodgkin disease/Lymphoma/DM/CRF/Malnutrition
⢠Children with increased exposure to tuberculosis disease
⢠Children often exposed to adults who are
ďHIV infected / homeless / Users of illicit drugs
ďResidents of nursing homes / Migrant farm workers
⢠Children who travel to high-prevalence regions of the world
TuberculousMeningitis
26
27. Induration âĽ15 mm
⢠Children âĽ4 yr of age without any risk factors
TuberculousMeningitis
27